Published in Cancer Weekly, June 24th, 2003
According to recent research published in the American Journal of Clinical Oncology, "In this phase II trial, we used the combination of gemcitabine and 5-fluorouracil (5-FU) to treat 26 patients: 17 (65%) with advanced pancreatic adenocarcinoma and nine (35%) with advanced biliary tract adenocarcinoma (10 locally advanced and 16 metastatic).
"There were 15 (57.7%) males and 11 (42.3%) females with a median age 58 (range, 39-68) and median performance status of 2 (range, 1-3). A total of 102 cycles were administered (median, 4 per patient). There were...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly